Not applicableStudy completedNCT02517892
What this trial is testing
A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents
Who this might be right for
Metastatic Oncogen-driven Cancer
Gustave Roussy, Cancer Campus, Grand Paris 1,500